Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAP

• DOI: 10.1021/ja074725f
• Publication Date: 2007-11-14T11:00:52Z
• Authors: Haiying Sun; Zaneta Nikolovska...; Jianfeng Lu; Jennifer L. Meagher; Chao-Yie Yang; Su Qiu; York Tomita; Yumi Ueda; Sheng Jiang; Krzysztof Krajewski; Peter P. Roller; Jeanne A. Stuckey; Shaomeng Wang
• Keywords: Models, Molecular; 0303 health sciences; Intracellular Signaling Peptides and Proteins; Antineoplastic Agents; Apoptosis; HL-60 Cells; X-Linked Inhibitor of Apoptosis Protein; Binding, Competitive; Protein Structure, Tertiary; 3. Good health; Mitochondrial Proteins; Inhibitory Concentration 50; Kinetics; 03 medical and health sciences; Biomimetic Materials; Caspases; Drug Design; Humans; Apoptosis Regulatory Proteins; Nuclear Magnetic Resonance, Biomolecular

XIAP is a central apoptosis regulator that inhibits apoptosis by binding to and inhibiting the effectors caspase-3/-7 and an initiator caspase-9 through its BIR2 and BIR3 domains, respectively. Smac protein in its dimeric form effectively antagonizes XIAP by concurrently targeting both its BIR2 and BIR3 domains. We report the design, synthesis, and characterization of a nonpeptide, cell-permeable, bivalent small-molecule (SM-164) which mimics Smac protein for targeting XIAP. Our study shows that SM-164 binds to XIAP containing both BIR domains with an IC50 value of 1.39 nM, being 300 and 7000 times more potent than its monovalent counterparts and the natural Smac AVPI peptide, respectively. SM-164 concurrently interacts with both BIR domains in XIAP and functions as an ultrapotent antagonist of XIAP in both cell-free functional and cell-based assays. SM-164 targets cellular XIAP and effectively induces apoptosis at concentrations as low as 1 nM in the HL-60 leukemia cell line. The potency of bivalent SM-164 in binding, functional, and cellular assays is 2-3 orders of magnitude higher than its corresponding monovalent Smac mimetics.